Silence Therapeutics (SLNCF) Other Non Operating Income (2020 - 2025)
Historic Other Non Operating Income for Silence Therapeutics (SLNCF) over the last 6 years, with Q3 2025 value amounting to $1.9 million.
- Silence Therapeutics' Other Non Operating Income rose 11697.09% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 million, marking a year-over-year increase of 15486.82%. This contributed to the annual value of $4.5 million for FY2024, which is 26932.98% up from last year.
- According to the latest figures from Q3 2025, Silence Therapeutics' Other Non Operating Income is $1.9 million, which was up 11697.09% from -$6.6 million recorded in Q2 2025.
- Silence Therapeutics' Other Non Operating Income's 5-year high stood at $357.1 million during Q1 2021, with a 5-year trough of -$357.0 million in Q3 2021.
- In the last 5 years, Silence Therapeutics' Other Non Operating Income had a median value of -$106492.8 in 2021 and averaged -$311203.5.
- The largest annual percentage gain for Silence Therapeutics' Other Non Operating Income in the last 5 years was 55326.31% (2024), contrasted with its biggest fall of 160951.57% (2024).
- Silence Therapeutics' Other Non Operating Income (Quarter) stood at -$106492.8 in 2021, then crashed by 434.19% to -$568870.2 in 2022, then crashed by 587.04% to -$3.9 million in 2023, then soared by 502.67% to $15.7 million in 2024, then tumbled by 87.71% to $1.9 million in 2025.
- Its Other Non Operating Income was $1.9 million in Q3 2025, compared to -$6.6 million in Q2 2025 and -$3.8 million in Q1 2025.